Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Rapidly changing landscape of precision medicine in Japan

WIN 2019 Symposium

23 - 24 Jun 2019

Published: 10 Jul 2019

Views: 932

Rating:

Save

Dr Sadakatsu Ikeda - Tokyo Medical and Dental University, Tokyo, Japan

Dr Sadakatsu Ikeda speaks to ecancer at the WIN 2019 Symposium in Paris about the rapidly changing landscape of precision medicine in Japan.

He explains that there has been recent approval for access to comprehensive genomic profiling in Japan, with between 5000 and 20,000 people per year expected to be available for this data capture.

Dr Ikeda also discusses the difficulties in accessing drugs following genomic sequencing due to the possible treatments being 'off-label'.

Related Videos

Hammamet Declaration on Oncogenetics in Africa: African Oncogenetics Network

Dr Timothy Rebbeck - Dana-Farber Cancer Institute, Boston, USA

Hammamet Declaration on Oncogenetics in Africa: African Oncogenetics Network ( Dr Timothy Rebbeck - Dana-Farber Cancer Institute, Boston, USA )

Key insights on breast cancer in Cape Verde

Dr Pamela Borges - Agostinho Neto University Hospital, Praia, Cape Verde

Key insights on breast cancer in Cape Verde ( Dr Pamela Borges - Agostinho Neto University Hospital, Praia, Cape Verde )

Addressing cancer control challenges in Africa

Dr Zainab Bagudu - MedicAid Cancer Foundation, Abuja, Nigeria

Addressing cancer control challenges in Africa ( Dr Zainab Bagudu - MedicAid Cancer Foundation, Abuja, Nigeria )

The case for global gender-neutral HPV vaccination

Peter Baker, Global Action on Men's Health (United Kingdom)

The case for global gender-neutral HPV vaccination ( Peter Baker, Global Action on Men's Health (United Kingdom) )

ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer

Prof Karim Fizazi, Dr Anders Bjartell, Dr Niven Mehra and Prof Eleni Efstathiou

ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer ( Prof Karim Fizazi, Dr Anders Bjartell, Dr Niven Mehra and Prof Eleni Efstathiou )

Genetic testing and targeted therapy in Ivory Coast

Dr Safiatou Coulibaly - Institute Pasteur De Côte D'ivoire, Adiopodoumé, Ivory Coast

Genetic testing and targeted therapy in Ivory Coast ( Dr Safiatou Coulibaly - Institute Pasteur De Côte D'ivoire, Adiopodoumé, Ivory Coast )

ASCO's strategic plan for cancer care in LMICs

Dr Lynn Schuchter - President, American Society of Clinical Oncology (ASCO), USA

ASCO's strategic plan for cancer care in LMICs ( Dr Lynn Schuchter - President, American Society of Clinical Oncology (ASCO), USA )

Synthetic biology and precision medicine in blood and gynaecological cancers

Dr Mutsa Takundwa - Council for Scientific and Industrial Research, Pretoria, South Africa

Synthetic biology and precision medicine in blood and gynaecological cancers ( Dr Mutsa Takundwa - Council for Scientific and Industrial Research, Pretoria, South Africa )

OncoAlert Round Up for September 15-21, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert Round Up for September 15-21, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

More from ecancer